awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26749870-8F715237-087D-4108-9832-783569E38D2E
Q26749870-8F715237-087D-4108-9832-783569E38D2E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26749870-8F715237-087D-4108-9832-783569E38D2E
Molecular and Cellular Mechanisms of Myelodysplastic Syndrome: Implications on Targeted Therapy
P2860
Q26749870-8F715237-087D-4108-9832-783569E38D2E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26749870-8F715237-087D-4108-9832-783569E38D2E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6f784fa555a53c427e31ee70bd69fe2f930d790a
P2860
Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia.